Jpmorgan Chase & CO Armata Pharmaceuticals, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 22 shares of ARMP stock, worth $71. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 25
12.0%
Holding current value
$71
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARMP
# of Institutions
29Shares Held
731KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA260KShares$845,2370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$339,7740.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$325,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$145,2160.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$130,9750.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $117M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...